Extracts produced from Viscum album L.(mistletoe) are widely used in complementary
medicine for the treatment of cancer. In many preclinical and clinical studies, Viscum album …

Purpose. European Mistletoe (Viscum album L.) extracts (mistletoe) are commonly used for
cancer treatment in Europe. This phase I study of gemcitabine (GEM) and mistletoe in …

Extracts and preparations from the tree parasitic plant mistletoe (Viscum album L.) have
been used in the treatment of cancer for decades. Numerous preclinical and in vitro studies …

Mistletoe lectin I (pML) and its isoforms ML II and III constitute the active principle in extract
preparations from mistletoe, commonly used as immunomodulator in adjuvant tumour …

There is still no therapy method in the colorectal cancers that is good enough for such a
complex disease. Combined surgery, chemotherapy, and radiotherapy improved survival …

European mistletoe (Viscum album L.) is a commonly occurring semiparasite of trees. The
extracts from European mistletoe have been shown to possess immunostimulatory and …

Mistletoe lectin is thought to constitute the active principle in extract preparations from
mistletoe, which are widely used as immunomodulators in adjuvant tumor therapy. However …

Numerous findings indicate that specific plant lectins acting against cancer could be major
active components of Viscum album extracts, although activity of low molecular weight …

Various microorganisms including mycobacteria, other bacteria, and parasites such as
Plasmodium falciparum are known to activate human γδ T-cells in vitro. In this study, we …

Mistletoe extracts have been shown to provide deoxyribonucleic acid (DNA)-stabilizing
effects in human peripheral blood mononuclear cells (PBMC) in vitro. We investigated the …